- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x SIA: N-acetyl-alpha-neuraminic acid(Non-covalent)
SIA.2: 8 residues within 4Å:- Chain A: G.32, K.58, N.59, S.62, Y.98
- Chain B: K.242, T.257
- Ligands: NAG.1
9 PLIP interactions:7 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:N.59, A:N.59, A:N.59, A:T.61, A:S.62, A:S.62, A:S.62, B:K.242, B:K.242
SIA.8: 11 residues within 4Å:- Chain B: L.31, G.32, K.58, N.59, S.62, P.64, Y.98
- Chain C: K.242, T.258, S.259
- Ligands: NAG.7
9 PLIP interactions:8 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:L.31, B:N.59, B:N.59, B:S.62, C:K.242
- Water bridges: B:T.61, B:S.62, B:S.62
- Salt bridges: B:K.58
SIA.14: 9 residues within 4Å:- Chain A: K.242, T.258, S.259
- Chain C: L.31, G.32, N.59, S.62, P.64, Y.98
11 PLIP interactions:7 interactions with chain C, 4 interactions with chain A- Hydrogen bonds: C:L.31, C:N.59, C:N.59, A:K.242, A:K.242, A:S.259
- Water bridges: C:T.61, C:T.61, C:S.62, C:Y.98
- Salt bridges: A:K.242
- 6 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 3 residues within 4Å:- Chain A: H.264, R.267
- Chain C: G.41
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:H.264, A:R.267
SO4.4: 6 residues within 4Å:- Chain A: R.44, E.94, K.269, T.270, E.271
- Chain B: H.264
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:E.94, A:E.271
- Water bridges: A:E.272
- Salt bridges: A:R.44, B:K.255, B:H.264
SO4.9: 5 residues within 4Å:- Chain A: L.40, G.41
- Chain B: H.264, R.267, Q.268
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.268
- Salt bridges: B:H.264, B:R.267
SO4.10: 5 residues within 4Å:- Chain B: R.44, E.94, T.270, E.271
- Chain C: H.264
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:E.271
- Water bridges: B:E.272
- Salt bridges: B:R.44, C:H.264
SO4.15: 7 residues within 4Å:- Chain A: H.264, Q.268
- Chain C: R.44, E.94, K.269, T.270, E.271
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: C:R.44, C:E.271, A:Q.268
- Salt bridges: A:H.264
SO4.16: 4 residues within 4Å:- Chain B: L.40
- Chain C: H.264, R.267, Q.268
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:Q.268
- Salt bridges: C:H.264, C:R.267
- Water bridges: B:L.40
- 2 x MVB: (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL(Non-covalent)
MVB.5: 8 residues within 4Å:- Chain A: G.336, W.337, P.340, M.341, L.347, K.393, M.438, P.440
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.347
- Salt bridges: A:K.393
MVB.17: 7 residues within 4Å:- Chain C: G.336, L.347, S.348, K.393, L.397, M.438, P.440
6 PLIP interactions:6 interactions with chain C- Water bridges: C:W.337, C:Y.345, C:L.347, C:K.393, C:D.394
- Salt bridges: C:K.393
- 4 x SMB: 2-METHYLBUTANOIC ACID(Non-covalent)
SMB.6: 3 residues within 4Å:- Chain A: G.123, S.201, H.447
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.201, A:S.201
- Water bridges: A:A.202
- Salt bridges: A:H.447
SMB.11: 4 residues within 4Å:- Chain B: G.122, G.123, S.201, H.447
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.201
- Water bridges: B:G.122
- Salt bridges: B:H.447
SMB.12: 2 residues within 4Å:- Chain B: L.347, K.393
2 PLIP interactions:2 interactions with chain B- Water bridges: B:K.393
- Salt bridges: B:K.393
SMB.18: 5 residues within 4Å:- Chain C: G.122, G.123, S.201, L.284, H.447
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:L.284
- Hydrogen bonds: C:G.123, C:S.201
- Water bridges: C:G.122
- Salt bridges: C:H.447
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fleming, C.D. et al., Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil. J.Mol.Biol. (2005)
- Release Date
- 2005-08-02
- Peptides
- CES1 protein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x SIA: N-acetyl-alpha-neuraminic acid(Non-covalent)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- 2 x MVB: (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL(Non-covalent)
- 4 x SMB: 2-METHYLBUTANOIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fleming, C.D. et al., Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil. J.Mol.Biol. (2005)
- Release Date
- 2005-08-02
- Peptides
- CES1 protein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C